Back

The effect of a diet reduction in advanced glycation end products on metabolic markers in patients with chronic coronary artery disease and type 2 diabetes.

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Nutrition Nutrition, Malnutrition and Heart Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Miss Karen Kuwabara

Mogi Das Cruzes (Brazil)

7 More presentations in this session

Presentation thumbnail
Adipose tissue content of monounsaturated fatty acids and the risk of myocardial infarction: a Danish case-cohort study
Mr J. Pedersen (Viborg, DK)
Abstract Slides Video
Presentation thumbnail
Healthy dietary patterns for the secondary prevention of cardiovascular diseases: a systematic review and meta-analysis of randomised controlled trials and prospective cohort studies
Doctor L. Oude Griep (Cambridge, GB)
Abstract Slides Video
Presentation thumbnail
Gut microbiota, lifestyle, and atherosclerosis: unravelling microbial contributions to cardiovascular risk
Doctor S. Filomia (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Effects of intermittent fasting and high-intensity interval training on cardiac remodeling and myocardial sestrins and AMP-activated protein kinase expression in healthy rats
Mrs P. Martinez (Campo Grande, BR)
Abstract Slides Video
Presentation thumbnail
Gut microbiota signatures in subclinical atherosclerosis: links to lipid metabolism and cardiovascular risk modulation
Doctor S. Morini (Rome, IT)
Abstract Slides Video

Access the full session

Session thumbnail
Nutrition

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Efficacy of diet with low glycemic index on coronary artery disease
thumbnail
Congress Presentation
Nutritional management, skipping breakfast, glycemic control, and cardiovascular risk on type 2 diabetes mellitus
thumbnail
Congress Presentation
Impact of impaired glucose metabolism on coronary atherosclerosis in patients with very low LDL cholesterol: a potential framework to understand residual risk in chronic coronary syndromes.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources